Skip to main content


Associate Professor
- Adjunct
Anne  Rositch

Departmental Affiliations

School of Medicine

Contact Info

615 N. Wolfe Street, Room E6150

Research Interests

Global Cancer epidemiology; Cervical cancer; Breast cancer; Cancer prevention and contol; Cancer in HIV/AIDS; Implementation Science; Cancer disparities and care equity
Experiences & Accomplishments
University of North Carolina at Chapel Hill
University of North Carolina at Chapel Hill
Dr. Anne F. Rositch is an applied epidemiologist, concentrating on cancer in women and global cancer disparities, with a background in basic science and experience conducting international field-based research. She received her PhD in Epidemiology from the University of North Carolina at Chapel Hill, and completed a post-doctoral fellowship in Cancer Epidemiology at Johns Hopkins. Currently, Dr. Rositch is an Associate Professor in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health, where co-teaches the first year Doctoral Seminar course, is a mentor on two NIH T32 training grants, and is a co-Director of the Doctoral Program.

For over 13 years, her research has focused on HPV and cervical cancer in HIV-positive individuals, aging women, and in low-resource settings. It has spanned the translational spectrum from epidemiological studies to understand the natural history of the disease, to studying the effectiveness and implementation of cervical cancer prevention in low-resource settings. Dr. Rositch has ongoing research in Baltimore, South America, and across sub-Saharan Africa. Her recent work is focused on leveraging her training in Implementation Science and experience in cervical cancer prevention to identify novel multidisciplinary and multilevel approaches for breast cancer control in low-resource settings. 

Dr. Rositch's current research program has three main areas: 1) epidemiology and prevention of HPV and invasive cervical cancer in aging and older women; 2) effectiveness and implementation of novel cervical and breast cancer prevention and control programs in high-risk populations and in low-resource settings including Peru, Tanzania, Kenya and South Africa; and 3) cancer and HIV, with a focus on treatment and survival disparities and on defining features of non-AIDS defining cancers in people with HIV/AIDS.
Select Publications
The papers below highlight the focus and variety of Dr. Rositch's research.
  • Rositch AF, Eshan P, Peterson M, Gravitt PE, Tobian AAR (2020). Prevalence of genital HPV infections in adult males and females in the United states by sexual behavior: implications on clinical decision making for adult HPV vaccination. Clinical Infectious Diseases, accepted. DOI: 10.1093/cid/ciaa1050
  • Rositch AF, Unger K, DeBoer R, Ng’ang’a A, Weiner B (2020). The role of dissemination and implementation science in global breast cancer control programs: frameworks, methods, and examples. Cancer, 126 Suppl 10:2394-2404. DOI: 10.1002/cncr.32877 .
  • Gravitt PE, Rositch AF, Jurczuk M, Meza G, Carillo L, Jeronimo J, Adsul P, Nervi L, Kosek M, Tracy JK, Paz-Soldan VA for the Proyecto PreCancer Study Group (2020). Systems Praxis for Implementation Research (INSPIRE): An implementation methodology to facilitate acceleration of the Global Elimination of Cervical Cancer screening and treatment goals. Cancer Epidemiology, Biomarkers and Prevention, 29(9):1710-1719. DOI: 10.1158/1055-9965.EPI-20-0501.
  • Rositch AF, Jiang S, Coghill A, Suneja G, Engels EA (2018). Disparities and determinants of cancer treatment in elderly Americans with HIV/AIDS. Clinical Infectious Diseases, 67 (12):1904–1911. DOI: 10.1093/cid/ciy373.
  • Beavis A, Gravitt PE, Rositch AF (2017). Hysterectomy corrected cervical cancer mortality rates reveal a larger racial disparity in the United States. Cancer 123(6):1044-1050. DOI: 10.1002/cncr.30507.
The Johns Hopkins Center for AIDS Research (JHU CFAR): Rositch, Anne
Proyecto PreCancer
Time to A.C.T.: implementing strategies for breast cancer control in Africa